microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer

被引:6
作者
Eapen, Mathew Suji [1 ]
McAlinden, Kielan Darcy [1 ]
Myers, Stephen [1 ]
Lu, Wenying [1 ]
Sohal, Sukhwinder Singh [1 ]
机构
[1] Univ Tasmania, Sch Hlth Sci, Dept Lab Med, Resp Translat Res Grp, Launceston, Tas 7248, Australia
关键词
microRNA; COPD; lung cancer; EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200; FAMILY; FREE-RADICALS; EXPRESSION; SMOKING; BIOMARKERS; HISTOLOGY; BLOCKADE; SMOKERS; DAMAGE;
D O I
10.3390/jcm8111986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
microRNAs (miRNAs) bind to mRNAs and inhibit their expression through post-transcriptionally regulating gene expression. Here, we elaborate upon the concise summary of the role of miRNAs in carcinogenesis with specific attention to precursor respiratory pathogenesis caused by cigarette smoke modulation of these miRNAs. We review how miRNAs are implicated in cigarette-smoke-driven mechanisms, such as epithelial to mesenchymal transition, autophagy modulation, and lung ageing, which are important in the development of chronic obstructive pulmonary disease and potential progression to lung cancer. Extracellular vesicles are key to inter-cellular communication and sharing of miRNAs. A deeper understanding of the role of miRNAs in chronic respiratory disease and their use as clinical biomarkers has great potential. Therapeutic targeting of miRNAs may significantly benefit the prevention of cancer progression.
引用
收藏
页数:6
相关论文
共 50 条
[31]   LUNG CANCER - A COMORBIDITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE [J].
Roca, M. ;
Roca, Iulia-Cristina ;
Mihaescu, T. .
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (04) :1055-1062
[32]   Static lung hyperinflation is an independent risk factor for lung cancer in patients with chronic obstructive pulmonary disease [J].
Zamarron, Ester ;
Prats, Eva ;
Tejero, Elena ;
Pardo, Paloma ;
Galera, Raul ;
Casitas, Raquel ;
Martinez-Ceron, Elisabet ;
Romera, Delia ;
Jaureguizar, Ana ;
Garcia-Rio, Francisco .
LUNG CANCER, 2019, 128 :40-46
[33]   Myeloid-Derived Suppressor Cells: Possible Link Between Chronic Obstructive Pulmonary Disease and Lung Cancer [J].
Scrimini, Sergio ;
Pons, Jaume ;
Sauleda, Jaume .
ARCHIVOS DE BRONCONEUMOLOGIA, 2016, 52 (01) :29-35
[34]   Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease [J].
Lim, Jiseun ;
Shin, Kyung Min ;
Lee, Kyung Soo ;
Lim, Jae Kwang ;
Kim, Hye Jung ;
Cho, Seung Hyun ;
Cha, Seung Ick .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (03) :540-545
[35]   Non-Coding RNAs as Key Regulators in Lung Cancer [J].
Gilyazova, Irina ;
Gimalova, Galiya ;
Nizamova, Aigul ;
Galimova, Elmira ;
Ishbulatova, Ekaterina ;
Pavlov, Valentin ;
Khusnutdinova, Elza .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
[36]   The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease [J].
Kim, Yeon Wook ;
Jin, Kwang-Nam ;
Heo, Eun Young ;
Park, Sung Soo ;
Chung, Hee Soon ;
Kim, Deog Kyeom .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :873-879
[37]   MicroRNAs in Lung Disease A Focus on Sarcoidosis [J].
Pattnaik, Bijay ;
Madan, Karan ;
Mohan, Anant ;
Mittal, Saurabh .
CHEST, 2020, 158 (02) :828-828
[38]   Neurohumoral activation as a link to systemic manifestations of chronic lung disease [J].
Andreas, S ;
Anker, SD ;
Scanlon, PD ;
Somers, VK .
CHEST, 2005, 128 (05) :3618-3624
[39]   BMI-mortality association: shape independent of smoking status but different for chronic lung disease and lung cancer [J].
Faeh, David ;
Kaufmann, Marco ;
Haile, Sarah R. ;
Bopp, Matthias .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 :1851-1855
[40]   Epidemiological evidence for associations between variants in CHRNA genes and risk of lung cancer and chronic obstructive pulmonary disease [J].
Yang, Lei ;
Yang, Zelin ;
Zuo, Chunjian ;
Lv, Xiaolong ;
Liu, Tianyu ;
Jia, Chenhao ;
Chen, Huanwen .
FRONTIERS IN ONCOLOGY, 2022, 12